Re: Sabizabulin - mCRPC- used now for Covid 19.
|
4
|
Zenith Epigenetics
|
Apr 14, 2022 06:46AM
|
Can Government finance option for Covid treatment
|
3
|
Resverlogix Corp.
|
Apr 05, 2022 04:45PM
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
6
|
Resverlogix Corp.
|
Mar 26, 2022 09:10AM
|
Re: RVX Board Thoughts Mar 18 2022 – Wishful Thinking
|
13
|
Resverlogix Corp.
|
Mar 19, 2022 01:31PM
|
Re: Deja Vu All Over Again
|
8
|
Resverlogix Corp.
|
Mar 13, 2022 10:25AM
|
Re: Deja Vu All Over Again
|
10
|
Resverlogix Corp.
|
Mar 13, 2022 09:16AM
|
Re: OTC Trading questions
|
1
|
Zenith Epigenetics
|
Mar 02, 2022 10:39AM
|
Re: OTC Trading questions
|
4
|
Zenith Epigenetics
|
Mar 02, 2022 10:20AM
|
Re: News out - Dosing of First Cancer Patient with a Combination of ZEN-3694 + Bristol Myers Squibb’s Immune Checkpoint Inhibitor OPDIV
|
6
|
Zenith Epigenetics
|
Feb 22, 2022 10:24AM
|
Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!
|
5
|
Zenith Epigenetics
|
Feb 11, 2022 12:21PM
|
Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!
|
5
|
Zenith Epigenetics
|
Feb 08, 2022 05:30PM
|
Pfizer Paxlovid, anti covid , dangerous with other drugs
|
7
|
Resverlogix Corp.
|
Jan 25, 2022 12:56PM
|
Re: Don on CTV Calgary News 6:18pm
|
2
|
Resverlogix Corp.
|
Jan 24, 2022 09:16PM
|
Re: I'm glad dosing has begun... How long until results...
|
3
|
Resverlogix Corp.
|
Jan 19, 2022 03:43PM
|
Re: Edmonton Journal Article
|
2
|
Resverlogix Corp.
|
Jan 19, 2022 12:10PM
|
Re: Edmonton Journal Article
|
1
|
Resverlogix Corp.
|
Jan 19, 2022 11:42AM
|
Re: Resverlogix Announces Commencement of Patient Enrollment and Dosing in a Phase 2b Trial for a Promising Canadian-Developed COVID-19 Treatment
|
7
|
Resverlogix Corp.
|
Jan 18, 2022 08:18AM
|
Time for a package deal??
|
7
|
Zenith Epigenetics
|
Jan 10, 2022 09:43AM
|
Re: Investment Banker?
|
6
|
Zenith Epigenetics
|
Jan 07, 2022 09:48AM
|
Re: Cases of COVID-19 infection are on the rise again in Brazil.
|
5
|
Resverlogix Corp.
|
Jan 05, 2022 11:55AM
|